We studied a 9-year-old boy, affected with the Parry-Romberg syndrome, during a period of 32 months, by means of clinical evaluations and neuroradiological magnetic resonance imaging. Over this time we observed a clinical progression of the cutaneous disease without a simultaneous progression of the neurological alterations. Conventional and advanced magnetic resonance imaging techniques showed white matter alterations which proved to be stable during the follow-up.
Introduction
Parry-Romberg syndrome (PRS) is a rare, sporadic, acquired disease characterised by a hemifacial progressive atrophy involving skin, subcutaneous tissue, muscles, cartilage and the underlying bone structures. 1 The pathogenesis of PRS is not well understood, and is thought to be heterogeneous. Trauma, infection, cranial vascular malformation, immunomediated processes are all hypothesised causes. 1 The onset of the facial alterations typically occurs in childhood or young adult age, usually beginning between the ages of 5 and 15 years. The soft tissue atrophy often progresses over a period of 2-10 years, and is followed by a period of clinical stability. 2 Variable therapeutic results have been reported using methotrexate, cytoxan and other immunosuppressive drugs but no treatment has been proved to stop PRS progression. 3 In about 15% of cases, PRS is associated with neurological manifestations, such as seizures and migraine. A wide range of brain abnormalities is possible: cerebral hemiatrophy, meningeal thickening, cortical dysgenesias, calcified lesions, 4,5 aneurysms, 6 vascular malformations and intracranial hemosiderin deposits. 7 Association with Rasmussen's encephalitis has also been reported. 2 Conventional magnetic resonance imaging (MRI) often shows white matter T2-hyperintensities, usually ipsilateral to facial alteration. 4, 8 To our knowledge there are no data in the literature about the neuroradiological evolution of cerebral alterations during a follow-up period.
Here, a neuroradiological 32-month follow-up of a 9-year-old child affected by PRS with cerebral involvement is presented. Both conventional and advanced MRI techniques, consisting of fractional anisotropy (FA), single and multi-voxel spectroscopy (H 1 -MRS) and fibre tracking, were used for this purpose.
In our case brain abnormalities remained stable also during cutaneous progression of the disease.
Case report and technical note
A 9-year-old boy was referred to our hospital after a 3year history of chronic daily migraine, sporadic episodes of focal seizures and specific learning disabilities.
At the age of 5 years, parents noticed an area of skin hyperpigmentation in the left frontal region which evolved in a progressive retractile scar. Dermatological and maxillofacial evaluation revealed skin atrophy in this region. A mild left enophtalmus was also evident. The neurological examination revealed a minor paresis of the right leg. Dyslexia was diagnosed according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria. Electroencephalographic examination showed asymmetry of the background activity, which was depressed and slowed in the posterior regions on the left hemisphere. Laboratory tests were normal, in particular those for autoimmunity.
When the patient came to our attention we performed the first conventional MRI that showed skullbrain asymmetry and T2-hyperintensities in the white matter of the left parietal, temporal and occipital lobes ( Figure 1 ). Hemosiderin deposits or calcifications were not detected. Magnetic resonance angiography did not show any aneurysms or vascular malformations. Spectroscopy demonstrated a slight reduction of Nacetyl-aspartate (NAA/Cr ¼ 1,2) in the altered white matter of the left hemisphere with the H 1 -MRS. FA showed a mildly decreased anisotropy in the affected area compared to the contralateral area, with preservation and symmetry of pyramidal tracts and of optic radiations (Figure 2) .
PRS was diagnosed on the basis of dermatological and brain MRI findings. The child was treated with immunoglobulins ev (1 g/kg, 2 days), pulse therapy with methylprednisolone (25 mg/kg, 5 days), and oral prednisone for 1 month (2 g per day, for the first two weeks; 1 g per day, for the second two weeks) for the possible autoimmune genesis of the disease. Topiramate, levetiracetam, carbamazepine and lomotrigine were used in order to control epilepsy and migraine attacks. Drug therapy was successful in controlling seizures but it was not significantly effective for migraine crisis.
In the follow-up, clinical and neuroradiological evaluations were performed every 6-8 months for a 32-month period, for a total of five MRI studies including spectroscopy and FA.
Follow-up studies showed a progression of the hemifacial atrophy, without further brain modifications either with conventional or with advanced techniques. 
Discussion
The first clinical presentation of PRS and progression typically occur in childhood or young adult age; despite this, there are only few data in the literature concerning paediatric patients. Intracranial involvement is best evaluated with MRI but we found only two studies based on advanced MRI techniques. 2, 3, [9] [10] [11] Moreover, those two studies achieved contradictory results: Longo et al. 2 reported a decrease of NAA in the affected brain areas while Okomura et al. 3 did not find any NAA alteration. In both papers, a follow-up study with H 1 -MRS was not performed. 2, 3 We used conventional and advanced MRI techniques to evaluate brain abnormalities and their temporal and spatial progression in a 9-year-old boy affected by PRS with neurological involvement. In particular, we performed five conventional and advanced MRI studies during a 32-month period, in a clinical phase of dermatological progression.
Conventional MRI documented a cerebral white matter T2-hyperintensity and quantitative reduction in the left parietal, temporal and occipital lobes, omolateral to facial hemiatrophy. The white matter alteration was also confirmed either by FA decrease and by NAA level reduction in the affected hemisphere, in accordance with the experience of Longo et al. 2, 3 Data obtained from both conventional and advanced MRI techniques were consistent with the diagnosis of white matter gliosis.
To the best of our knowledge, there are currently no data in the literature on whether the cerebral alteration often documented in PRS patients could change over time or not. No neuroradiological studies comparing clinical progression and MRI findings have ever been published.
By means of a close follow-up, we documented a stability of the brain involvement in terms of the extent of the area of altered magnetic resonance signal and of spectroscopic and FA data. Notably, this stability in the brain involvement was found while progression of skin alterations was evident both clinically and on the magnetic resonance images.
Fibre-tracking analysis documented the integrity of the principal white matter pathways (corpus callosum, optic radiation, pyramidal tracts and descending fibres of the pons), as was reported by Okomura et al. 3 In our case this finding has to be correlated with the site of brain alterations, which does not involve these pathways.
It is very interesting to highlight the link between the localisation of the disease and the visuoperceptive impairment, which resulted in dyslexia. In fact the left deep parietal region is located in the occipital-parietal pathway (the so-called dorsal stream of the associative visual pathways).
In conclusion, our study is the first with a clinical and neuroradiological 3-year follow-up. It presents several points of interest and adds some new relevant data, referring to a paediatric patient studied during a period of active disease. Over this time we found no simultaneous progression of the cutaneous and neurological alterations.
Conventional and advanced MRI techniques showed a pattern of alterations, without significant modification over time, even in a phase of cutaneous progression.
This could suggest that a close radiological followup is not necessary in the case of clinical neurological stability.
